Angels Ginès

Angels Ginès

Auto-generated profile, based on publicly available information

Angels Ginès

Hospital Clinic de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in Neurology
Verified
Journal Article
Open access
PDF file
FSFabienne S. Sprenger
Fabienne S. Sprenger
NSNadia Stefanova
Nadia Stefanova
EGEllen Gelpi
Ellen Gelpi
KSKlaus Seppi
Klaus Seppi
JNJudith Navarro-Otano
Judith Navarro-Otano
WPWerner Poewe
Werner Poewe
Objective: To investigate the expression of α-synuclein in colonic biopsies of patients with idiopathic REM sleep behavior disorder (iRBD) and address if α-synuclein immunostaining of tissue obtained via colonic biopsies holds promise as a diagnostic biomarker for prodromal Parkinson disease (PD). Methods: Patients with iRBD, patients with PD, and healthy controls were prospectively recruited to undergo colonic biopsies for comparison of α-synuclein immunoreactivity patterns between the groups by using 2 different antibodies. Results: There was no difference in colonic mucosal and submucosal immunostaining between groups using the 15G7 α-synuclein antibody, which was found in almost all participants enrolled in this study. By contrast, immunostaining for serine 129-phosphorylated α-synuclein (pSyn) in submucosal nerve fibers or ganglia was found in none of 14 controls but was observed in 4 of 17 participants with iRBD and 1 out of 19 patients with PD. Conclusions: The present findings of pSyn immunostaining of colonic biopsies in a substantial proportion of iRBD participants raise the possibility that this tissue marker may be a suitable candidate to study further as a prodromal PD marker in at-risk cohorts.

1 February 1994 in Seminars in Liver Disease
Verified
Journal Article
Closed access
PDF file
XFX. Forns
X. Forns
AGA. Ginès
A. Ginès
PGP. Ginès
P. Ginès
VAV. Arroyo
V. Arroyo

22 May 2010 in Medicina Clinica
Verified
Journal Article
Closed access
SNSalvador Navarro
Salvador Navarro
EVEva Vaquero
Eva Vaquero
Joan MaurelJoan Maurel
Joan Maurel
JBJosep Antoni Bombí
Josep Antoni Bombí
CJCarmen De Juan
Carmen De Juan
LSLuis Sabater
Luis Sabater

1 May 2015 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
GFGloria Fernández-Esparrach
Gloria Fernández-Esparrach
NANadia Alberghina
Nadia Alberghina
JSJosé Carlos Subtil
José Carlos Subtil
EVEnrique Vázquez-Sequeiros
Enrique Vázquez-Sequeiros
VFVivian Florio
Vivian Florio
AGAngels Ginès
Angels Ginès
Endoscopic ultrasound-guided fine needle aspiration is highly accurate for the diagnosis of malignancies surrounding the gastrointestinal tract. There is a lack of information on the usefulness of this technique in the diagnosis of colorectal cancer recurrence. The purpose of this work was to investigate the performance characteristics of endoscopic ultrasound-guided fine needle aspiration for the cytologic diagnosis of perirectal recurrence of colorectal cancer. This was a retrospective study on the clinical and radiologic suspicion of perirectal recurrence of colorectal cancer. The study was conducted at 4 tertiary hospitals. Consecutive patients with suspicion of perirectal recurrence of colorectal cancer undergoing endoscopic ultrasound-guided fine needle aspiration between 2000 and 2013 were included in this study. The study intervention was endoscopic ultrasound-guided fine needle aspiration. Endoscopic ultrasound-guided fine needle aspiration performance characteristics and outcome (malignant or benign) were analyzed. The gold standard was cytologic results if malignancy or follow-up if benignity. A total of 58 patients were included (32 men; mean age, 64.2 ± 10.0 years [range, 44-88 years]). The location of the initial neoplasm was the rectum for 42 patients and the colon for 16 patients. Endoscopic ultrasound findings included a mass in the anastomosis (n = 8), perirectal fat (n = 23), lymph nodes (n = 20), or asymmetric thickness of the rectal wall (n = 6). Cytology showed malignancy in 38 patients (67%), benign features in 17 (30%), and was not evaluable in 2. Mean follow-up to confirm a benign outcome was 51.3 ± 30.3 months (range, 5.2-180.0 months). Final outcome was recurrence in 40 patients (69%) and benignity in 18 patients (31%). Performance characteristics of endoscopic ultrasound-guided fine needle aspiration were sensitivity (97%), specificity (100%), positive predictive value (100%), negative predictive value (94%), and accuracy (98%). In the intention to diagnose analysis, the corresponding values were 95%, 100%, 100%, 90%, and 96%. This was a retrospective series with a limited number of patients. Endoscopic ultrasound-guided fine needle aspiration is a highly accurate tool for the cytologic diagnosis of perirectal recurrence in patients with previous colorectal cancer.

1 July 2014 in Pancreatology
Verified
Journal Article
Closed access
EVEva C. Vaquero
Eva C. Vaquero
MSMaria T. Salcedo
Maria T. Salcedo
Miriam CuatrecasasMiriam Cuatrecasas
Miriam Cuatrecasas
HLHannah De León
Hannah De León
XMXavier Merino
Xavier Merino
XMXavier Molero
Xavier Molero

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
XGXabier García-Albéniz
Xabier García-Albéniz
RGRosa Gallego
Rosa Gallego
RHRalf Dieter Hofheinz
Ralf Dieter Hofheinz
GFGloria Fernández-Esparrach
Gloria Fernández-Esparrach
JAJuan Ramón Ayuso-Colella
Juan Ramón Ayuso-Colella
JMJoan Maurel
Joan Maurel
AIM: To evaluate the long-term results of conventional chemoradiotherapy and laparoscopic mesorectal excision in rectal adenocarcinoma patients without adjuvant therapy. METHODS: Patients with biopsy-proven adenocarcinoma of the rectum staged cT3-T4 by endoscopic ultrasound or magnetic resonance imaging received neoadjuvant continuous infusion of 5-fluorouracil for five weeks and concomitant radiotherapy. Laparoscopic surgery was planned after 5-8 wk. Patients diagnosed with ypT0N0 stage cancer were not treated with adjuvant therapy according to the protocol. Patients with ypT1-2N0 or ypT3-4 or N+ were offered 5-fluorouracil-based adjuvant treatment on an individual basis. An external cohort was used as a reference for the findings. RESULTS: One hundred and seventy six patients were treated with induction chemoradiotherapy and 170 underwent total mesorectal excision. Cancer staging of ypT0N0 was achieved in 26/170 (15.3%) patients. After a median follow-up of 58.3 mo, patients with ypT0N0 had five-year disease-free and overall survival rates of 96% (95%CI: 77-99) and 100%, respectively. We provide evidence about the natural history of patients with localized rectal cancer achieving a complete response after preoperative chemoradiation. The inherent good prognosis of these patients will have implications for clinical trial design and care of patients. CONCLUSION: Withholding adjuvant chemotherapy after complete response following standard neoadjuvant chemoradiotherapy and laparoscopic mesorectal excision might be safe within an experienced multidisciplinary team.